Beranda › Edema Makula › Florida
Uji klinis Edema Makula di Florida
5 studi untuk Edema Makula mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Retina Group of Florida - Fort Lauderdale Retina Center, Fort Lauderdale
- Florida Retina Institute, Jacksonville Southside, Jacksonville
- Advanced Research Institute, Pompano Beach
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06962839A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Retina Vitreous Associates of Florida ( Site 0034), Tampa
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Center for Retina and Macular Disease ( Site 0047), Winter Haven
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07705607A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
- Florida Eye Clinic, Altamonte Springs
- Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale
- Retina Vitreous Associates of Florida (St. Petersburg), St. Petersburg
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
- Florida Eye Clinic, Altamonte Springs
- Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale
- Retina Vitreous Associates of Florida (St. Petersburg), St. Petersburg
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT06996080Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.